{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:23:14Z","timestamp":1785327794683,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["2198 to EC"],"award-info":[{"award-number":["2198 to EC"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2016-0874"],"award-info":[{"award-number":["2016-0874"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Health (Ricerca Corrente) funding program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The longevity-associated variant (LAV) of the bactericidal\/permeability-increasing fold-containing family B member 4 (BPIFB4) has been found significantly enriched in long-living individuals. Neuroinflammation is a key player in Huntington\u2019s disease (HD), a neurodegenerative disorder caused by neural death due to expanded CAG repeats encoding a long polyglutamine tract in the huntingtin protein (Htt). Herein, we showed that striatal-derived cell lines with expanded Htt (STHdh Q<jats:sup>111\/111<\/jats:sup>) expressed and secreted lower levels of BPIFB4, when compared with Htt expressing cells (STHdh Q<jats:sup>7\/7<\/jats:sup>), which correlated with a defective stress response to proteasome inhibition. Overexpression of LAV-BPIFB4 in STHdh Q<jats:sup>111\/111<\/jats:sup> cells was able to rescue both the BPIFB4 secretory profile and the proliferative\/survival response. According to a well-established immunomodulatory role of LAV-BPIFB4, conditioned media from LAV-BPIFB4-overexpressing STHdh Q111<jats:sup>\/111<\/jats:sup> cells were able to educate Immortalized Human Microglia\u2014SV40 microglial cells. While STHdh Q<jats:sup>111\/111<\/jats:sup> dying cells were ineffective to induce a CD163\u2009+\u2009IL-10<jats:sup>high<\/jats:sup> pro-resolving microglia compared to normal STHdh Q<jats:sup>7\/7<\/jats:sup>, LAV-BPIFB4 transduction promptly restored the central immune control through a mechanism involving the stromal cell-derived factor-1. In line with the in vitro results, adeno-associated viral-mediated administration of LAV-BPIFB4 exerted a CXCR4-dependent neuroprotective action in vivo in the R6\/2 HD mouse model by preventing important hallmarks of the disease including motor dysfunction, body weight loss, and mutant huntingtin protein aggregation. In this view, LAV-BPIFB4, due to its pleiotropic ability in both immune compartment and cellular homeostasis, may represent a candidate for developing new treatment for HD.<\/jats:p>","DOI":"10.1038\/s41419-020-02754-w","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T06:02:39Z","timestamp":1595052159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum\u2013microglia crosstalk preventing disease progression in a mouse model of Huntington\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Alba","family":"Di Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-4583","authenticated-orcid":false,"given":"Elena","family":"Ciaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Maciag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lopardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-6657","authenticated-orcid":false,"given":"Francesco","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albino","family":"Carrizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Damato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Marracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0832-2472","authenticated-orcid":false,"given":"Alberto","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Vecchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6906-7372","authenticated-orcid":false,"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-1460","authenticated-orcid":false,"given":"Annibale A.","family":"Puca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"key":"2754_CR1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/B978-0-12-381328-2.00014-6","volume":"98","author":"A Reiner","year":"2011","unstructured":"Reiner, A., Dragatsis, I. & Dietrich, P. Genetics and neuropathology of Huntington\u2019s disease. Int. Rev. Neurobiol. 98, 325\u2013372 (2011).","journal-title":"Int. Rev. Neurobiol."},{"key":"2754_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ncl.2014.09.003","volume":"33","author":"P Dayalu","year":"2015","unstructured":"Dayalu, P. & Albin, R. L. Huntington disease: pathogenesis and treatment. Neurol. Clin. 33, 101\u2013114 (2015).","journal-title":"Neurol. Clin."},{"key":"2754_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/B978-0-12-801893-4.00001-8","volume":"144","author":"MA Nance","year":"2017","unstructured":"Nance, M. A. Genetics of Huntington disease. Handb. Clin. Neurol. 144, 3\u201314 (2017).","journal-title":"Handb. Clin. Neurol."},{"key":"2754_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-007-0306-6","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel, J. P. Huntington disease models and human neuropathology: similarities and differences. Acta Neuropathol. 115, 55\u201369 (2008).","journal-title":"Acta Neuropathol."},{"key":"2754_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A. & Tabrizi, S. J. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10, 83\u201398 (2011).","journal-title":"Lancet Neurol."},{"key":"2754_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/b978-0-444-52014-2.00001-x","volume":"100","author":"KM Shannon","year":"2011","unstructured":"Shannon, K. M. Huntington\u2019s disease\u2014clinical signs, symptoms, presyntomatic diagnosis, and diagnosis. Handb. Clin. Neurol. 100, 3\u201313, https:\/\/doi.org\/10.1016\/b978-0-444-52014-2.00001-x (2011).","journal-title":"Handb. Clin. Neurol."},{"key":"2754_CR7","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1007\/s12035-018-1393-1","volume":"56","author":"M Garcia-Miralles","year":"2019","unstructured":"Garcia-Miralles, M. et al. Laquinimod treatment improves myelination deficits at the transcriptional and ultrastructural levels in the YAC128 mouse model of Huntington disease. Mol. Neurobiol. 56, 4464\u20134478 (2019).","journal-title":"Mol. Neurobiol."},{"key":"2754_CR8","unstructured":"Carroll, J. Disappointing news from LEGATO-HD trial of laquinimod in Huntington\u2019s disease. HDBuzz 1\u20134 (2018) https:\/\/en.hdbuzz.net\/262."},{"issue":"8","key":"2754_CR9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R. M. A polarizing question: do M1 and M2 microglia exist? Nat. Neurosci. 19(8), 987\u2013991 (2016).","journal-title":"Nat. Neurosci."},{"key":"2754_CR10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2015.06.010","volume":"154","author":"Y Nakagawa","year":"2015","unstructured":"Nakagawa, Y. & Chiba, K. Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol. Ther. 154, 21\u201335 (2015).","journal-title":"Pharmacol. Ther."},{"key":"2754_CR11","first-page":"1","volume":"13","author":"CY Liu","year":"2019","unstructured":"Liu, C. Y., Wang, X., Liu, C. & Zhang, H. L. Pharmacological targeting of microglial activation: new therapeutic approach. Front. Cell. Neurosci. 13, 1\u201319 (2019).","journal-title":"Front. Cell. Neurosci."},{"key":"2754_CR12","first-page":"60","volume":"1","author":"G Liu","year":"2012","unstructured":"Liu, G. et al. Neuronal phagocytosis by inflammatory macrophages in ALS spinal cord: Inhibition of inflammation by resolvin D1. Am. J. Neurodegener. Dis. 1, 60\u201374 (2012).","journal-title":"Am. J. Neurodegener. Dis."},{"key":"2754_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-45","volume":"7","author":"AI Ferger","year":"2010","unstructured":"Ferger, A. I. et al. Effects of mitochondrial dysfunction on the immunologicalproperties of microglia. Neuroinflammation 7, 1\u201310 (2010).","journal-title":"Neuroinflammation"},{"key":"2754_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2019.00258","volume":"12","author":"TH Palpagama","year":"2019","unstructured":"Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M. & Kwakowsky, A. The Role of Microglia and Astrocytes in Huntington\u2019s Disease. Front. Mol. Neurosci. 12, 1\u201315 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"2754_CR15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","volume":"36","author":"A Crotti","year":"2015","unstructured":"Crotti, A. & Glass, C. K. The choreography of neuroinflammation in Huntington\u2019s disease. Trends Immunol. 36, 364\u2013373 (2015).","journal-title":"Trends Immunol."},{"key":"2754_CR16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1165\/rcmb.2014-0297RT","volume":"52","author":"CJ Britto","year":"2015","unstructured":"Britto, C. J. & Cohn, L. Bactericidal\/permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease. Am. J. Respir. Cell Mol. Biol. 52, 525\u201334 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"Supplement_1","key":"2754_CR17","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/gerona\/glz036","volume":"74","author":"E Ciaglia","year":"2019","unstructured":"Ciaglia, E. et al. Longevity-associated variant of BPIFB4 mitigates monocyte-mediated acquired immune response. J. Gerontol. A. Biol. Sci. Med. Sci. 74(Supplement_1), S38\u2013S44 (2019).","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"2754_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-015-0054-8","volume":"12","author":"F Villa","year":"2015","unstructured":"Villa, F. et al. Serum BPIFB4 levels classify health status in long-living individuals. Immun. Ageing 12, 1\u20137 (2015).","journal-title":"Immun. Ageing"},{"key":"2754_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01034","volume":"11","author":"E Ciaglia","year":"2020","unstructured":"Ciaglia, E. et al. Circulating BPIFB4 levels associate with and influence the abundance of reparative monocytes and macrophages in Long Living Individuals. Front. Immunol. 11, 1\u20138 (2020).","journal-title":"Front. Immunol."},{"key":"2754_CR20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.117.305875","volume":"117","author":"F Villa","year":"2015","unstructured":"Villa, F. et al. Genetic analysis reveals a longevity-associated protein modulating endothelial function and angiogenesis. Circ. Res. 117, 333\u201345 (2015).","journal-title":"Circ. Res."},{"key":"2754_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/cvr\/cvx072","volume":"113","author":"CC Spinelli","year":"2017","unstructured":"Spinelli, C. C. et al. LAV-BPIFB4 isoform modulates eNOS signalling through Ca2+\/PKC-alpha-dependent mechanism. Cardiovasc. Res. 113, 5\u2013804, https:\/\/doi.org\/10.1093\/cvr\/cvx072 (2017).","journal-title":"Cardiovasc. Res."},{"key":"2754_CR22","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.18632\/aging.102209","volume":"11","author":"M Malavolta","year":"2019","unstructured":"Malavolta, M. et al. LAV-BPIFB4 associates with reduced frailty in humans and its transfer prevents frailty progression in old mice. Aging 11, 6555\u20136568 (2019).","journal-title":"Aging"},{"key":"2754_CR23","doi-asserted-by":"publisher","unstructured":"Puca, A. A. et al. Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism. Eur. Heart J. 1\u201312 https:\/\/doi.org\/10.1093\/eurheartj\/ehz459 (2019).","DOI":"10.1093\/eurheartj\/ehz459"},{"key":"2754_CR24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","volume":"1792","author":"RJ Ferrante","year":"2009","unstructured":"Ferrante, R. J. Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochim. Biophys. Acta 1792, 506\u2013520 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"2754_CR25","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9, 2799\u20132809 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"2754_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1937-6448(08)00602-3","volume":"267","author":"IM Konstantinova","year":"2008","unstructured":"Konstantinova, I. M., Tsimokha, A. S. & Mittenberg, A. G. Role of proteasomes in cellular regulation. Int. Rev. Cell. Mol. Biol. 267, 59\u2013124 (2008).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"2754_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037929","volume":"7","author":"SM Chafekar","year":"2012","unstructured":"Chafekar, S. M. & Duennwald, M. L. Impaired heat shock response in cells expressing full-length polyglutamine-expanded huntingtin. PLoS ONE 7, e37929 (2012).","journal-title":"PLoS ONE"},{"key":"2754_CR28","doi-asserted-by":"publisher","unstructured":"Dang, Z et al. Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF-1\/CXCR4 signalling pathway. Eur. J. Heart. Fail. (2020) https:\/\/doi.org\/10.1002\/ejhf.1840.","DOI":"10.1002\/ejhf.1840"},{"key":"2754_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1182\/blood-2009-12-258186","volume":"117","author":"L S\u00e1nchez-Mart\u00edn","year":"2011","unstructured":"S\u00e1nchez-Mart\u00edn, L. et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 117, 88\u201397 (2011).","journal-title":"Blood"},{"key":"2754_CR30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archinternmed.2007.75","volume":"168","author":"DF Terry","year":"2010","unstructured":"Terry, D. F., Sebastiani, P., Andersen, S. L. & Perls, T. T. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch. Intern. Med. 168, 277\u2013283 (2010).","journal-title":"Arch. Intern. Med."},{"key":"2754_CR31","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1073\/pnas.122587599","volume":"99","author":"TT Perls","year":"2002","unstructured":"Perls, T. T. et al. Life-long sustained mortality advantage of siblings of centenarians. Proc. Natl Acad. Sci. USA 99, 8442\u20138447 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2754_CR32","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1073\/pnas.1120658109","volume":"109","author":"H Heyn","year":"2012","unstructured":"Heyn, H. et al. Distinct DNA methylomes of newborns and centenarians. Proc. Natl Acad. Sci. USA 109, 10522\u201310527(2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2754_CR33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou, Y. et al. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 15, 565\u2013581 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"2754_CR34","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","volume":"2013","author":"G Ellrichmann","year":"2013","unstructured":"Ellrichmann, G., Reick, C., Saft, C. & Linker, R. The role of the immune system in Huntington\u2019s disease. Clin. Dev. Immunol. 2013, 541259 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"2754_CR35","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/glia.20526","volume":"55","author":"DA Simmons","year":"2007","unstructured":"Simmons, D. A. et al. Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington\u2019s disease. Glia 55, 1074\u20131084 (2007).","journal-title":"Glia"},{"key":"2754_CR36","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"FN Pavese","year":"2006","unstructured":"Pavese, F. N. et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66, 1638\u20131643 (2006).","journal-title":"Neurology"},{"key":"2754_CR37","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai, Y. F. et al. Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130, 1759\u20131766 (2007).","journal-title":"Brain"},{"key":"2754_CR38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2015.08.011","volume":"83","author":"M Politis","year":"2015","unstructured":"Politis, M. et al. Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington\u2019s disease gene carriers. Neurobiol. Dis. 83, 115\u2013121 (2015).","journal-title":"Neurobiol. Dis."},{"key":"2754_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnagi.2017.00193","volume":"9","author":"HM Yang","year":"2017","unstructured":"Yang, H. M., Yang, S., Huang, S. S., Tang, B. S. & Guo, J. F. Microglial activation in the pathogenesis of Huntington\u2019s disease. Front. Aging Neurosci. 9, 193 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"2754_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang, K. H., Wu, Y. R., Chen, Y. C. & Chen, C. M. Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav. Immun. 44, 121\u2013127 (2015).","journal-title":"Brain Behav. Immun."},{"key":"2754_CR41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semcancer.2008.11.001","volume":"19","author":"M Li","year":"2009","unstructured":"Li, M. & Ransohoff, R. M. The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin. Cancer Biol. 19, 111\u2013115 (2009).","journal-title":"Semin. Cancer Biol."},{"key":"2754_CR42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1189\/jlb.0909602","volume":"88","author":"N Karin","year":"2010","unstructured":"Karin, N. The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease. J. Leukoc. Biol. 88, 463\u201373 (2010).","journal-title":"J. Leukoc. Biol."},{"issue":"1459","key":"2754_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2012.04.011","volume":"12","author":"Q Wang","year":"2012","unstructured":"Wang, Q. et al. Stromal cell-derived factor 1\u03b1 decreases \u03b2-amyloid deposition in Alzheimer\u2019s disease mouse model. Brain Res. 12(1459), 15\u201326 (2012).","journal-title":"Brain Res."},{"key":"2754_CR44","doi-asserted-by":"crossref","first-page":"11068","DOI":"10.1073\/pnas.1006375107","volume":"107","author":"KS Carbajal","year":"2010","unstructured":"Carbajal, K. S., Schaumburg, C., Strieter, R., Kane, J. & Lane, T. E. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl Acad. Sci. USA 107, 11068\u201311073 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2754_CR45","first-page":"2179","volume":"9","author":"R Chang","year":"2015","unstructured":"Chang, R., Liu, X., Li, S. & Li, X. J. Transgenic animal models for study of the pathogenesis of Huntington\u2019s disease and therapy. Drug Des. Devel. Ther. 9, 2179\u20132188 (2015).","journal-title":"Drug Des. Devel. Ther."},{"key":"2754_CR46","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder, A. et al. The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci. Rep. 7, 1307 (2017).","journal-title":"Sci. Rep."},{"key":"2754_CR47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"2754_CR48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0962-8924(97)88136-6","volume":"7","author":"SW Davies","year":"1997","unstructured":"Davies, S. W. & Scherzinger, E. Nuclear inclusions in Huntington\u2019s disease. Trends Cell. Biol. 7, 422 (1997).","journal-title":"Trends Cell. Biol."},{"key":"2754_CR49","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter, R. J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J. Neurosci. 19, 3248\u20133257 (1999).","journal-title":"J. Neurosci."},{"key":"2754_CR50","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1523\/JNEUROSCI.23-11-04601.2003","volume":"23","author":"SH Chalasani","year":"2003","unstructured":"Chalasani, S. H. et al. The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J. Neurosci. 23, 4601\u20134612 (2003).","journal-title":"J. Neurosci."},{"key":"2754_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.07.003","volume":"89","author":"E Ciaglia","year":"2014","unstructured":"Ciaglia, E. et al. N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice. Pharm. Res. 89, 1\u201310 (2014).","journal-title":"Pharm. Res."},{"key":"2754_CR52","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ab.2010.02.036","volume":"2","author":"I Romero-Calvo","year":"2010","unstructured":"Romero-Calvo, I. et al. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal. Biochem. 2, 318\u2013320 (2010).","journal-title":"Anal. Biochem."},{"key":"2754_CR53","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","volume":"14","author":"A Di Pardo","year":"2018","unstructured":"Di Pardo, A. et al. Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease. Hum. Mol. Genet. 14, 2490\u20132501 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"2754_CR54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fnmol.2019.00100","volume":"12","author":"A Di Pardo","year":"2019","unstructured":"Di Pardo, A. et al. Stimulation of sphingosine kinase 1 (SPHK1) is beneficial in a Huntington\u2019s disease pre-clinical model. Front. Mol. Neurosci. 12, 100 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"2754_CR55","doi-asserted-by":"crossref","first-page":"175 91","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F. et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175 91 (2007).","journal-title":"Behav. Res. Methods"},{"key":"2754_CR56","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1073\/pnas.1114502109","volume":"109","author":"A Di Pardo","year":"2012","unstructured":"Di Pardo, A. et al. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc. Natl Acad. Sci. USA 109, 3528\u20133533 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2754_CR57","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Di Pardo","year":"2014","unstructured":"Di Pardo, A. et al. FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum. Mol. Genet. 23, 2251\u20132265 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"2754_CR58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 3 (2011).","journal-title":"EMBnet J."},{"key":"2754_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2754_CR60","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/nar\/30.1.38","volume":"30","author":"T Hubbard","year":"2002","unstructured":"Hubbard, T. et al. The Ensembl genome database project. Nucleic Acids Res. 30, 38\u201341 (2002).","journal-title":"Nucleic Acids Res."},{"key":"2754_CR61","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"2754_CR62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"issue":"Database issue","key":"2754_CR63","first-page":"D377","volume":"41","author":"H Mi","year":"2013","unstructured":"Mi, H., Muruganujan, A. & Thomas, P. D. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 41(Database issue), D377\u2013D386 (2013).","journal-title":"Nucleic Acids Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02754-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02754-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02754-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:09:43Z","timestamp":1760087383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02754-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2754"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02754-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A.P. and C.V. hold shares of LGV1 start-up, a spin-off of University of Salerno that own patents on LAV-BPIFB4 use in therapy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"546"}}